十大MNC+三大科研院所共赴2026BPD新加坡！全日程重磅更新
2026BPDSingapore将于9 22-23InMarina Bay Sands Singapore Convention & Exhibition Centre举办。作为BPD生物药工艺发展大会全球化战略布局的重要一站，大会由易贸医疗主办、药明合联再度协办，现场将邀请 500+ 参会者，50+ 讲者，设置技术论坛、CEO闭门会、BPD NIGHT、1-on-1 Meeting等多元环节，聚焦东南亚工艺产能合作、市场准入与区域合规，搭建中国药企、供应商与东南亚药企的合作桥梁，抢占出海东南亚窗口期。
目前，十大MNC、三大新加坡顶尖科研院所Confirmed attendance at 2026BPD Singapore. Key agenda items updated.
十大MNC链接全球产业资源
Southeast Asia正成为全球生物医药产业增长最快的区域之一，其中新加坡凭借成熟的金融体系、完善的知识产权保护和高端制造生态，成为MNC布局亚太乃至全球的战略支点。
AbbVie于2024年宣布斥资2.23亿美元扩建新加坡生物制剂生产基地，新增2.4万升产能，预计2026年投入运营；GSK、Novartis、PfizerThey also maintain significant operations in Singapore. This deep concentration of global giants not only highlights Singapore's value as a regional hub but also underscores the opportunities for industrial advancement across Southeast Asia.
截至目前，十大MNC已确认参与2026BPD新加坡，为大会带来全球前沿的工艺技术视野与商业化实践经验。
三大顶尖科研力量齐聚
新加坡作为亚洲生物医药创新高地，其科研实力备受全球瞩目。本届BPD新加坡已汇聚新加坡三大顶尖科研院所，包括：
A*STAR BTI
Nanyang Technological University
National University of Singapore
此外，印尼BPOM、马来药监NPRA & 协会MOPI、泰国Nouvogenes Therapeutics等东南亚监管机构、行业协会与企业代表亦将深度参与。科研端与产业端的深度融合，将为生物药工艺创新提供源源不断的源头动力。
大会日程
【9/22】
BPD Plenary Forum
Global Vision: Biopharmaceutical Supply Chain Restructuring and Process Ecosystem Collaboration
09:00-09:05 Welcome Address
Speaker:Vera Deng, Enmore BIO, Founder & CEO
09:05-09:10 Opening Remarks
Speaker:Jimmy Li, WuXi XDC, CEO
09:10–09:40 Dialogue: A New Paradigm for the Globalization of China's Biopharmaceuticals: From Process Innovation to Ecosystem Collaboration
Speaker:Chris Chen, WuXi Biologics, CEO
09:40–10:20 Panel Discussion: Cross-border Synergy & Bilateral Co-Development: China going Global and Southeast Asian Industrial Ecosystem under Global Supply Chain Restructure
Panelist:Jimmy Li, WuXi XDC, CEO
Bo Ying, Abogen Biosciences, CEO
Tony Xue, MediLinkTherapeutics, Founder & CEONEW
10:20–10:50 Tea break & Networking
Regional Deep Dive: Asia Strategy to Southeast Asia Execution
10:50–11:10 Keynote speech: Strategic framework and practical roadmap for Chinese pharmaceuticals entering Southeast Asian market
Speaker:Clement Yau, Temasek Lifesciences Accelerator, VP, Investments
11:10–12:00 Panel Discussion: From Partnership to Value Co-Creation, Practical Challenges and Breakthrough Solutions for Cross-Border Pharmaceuticals between China and Southeast Asia
Panelist: Lawrence,Rxilient, CEONEW
PengfeiChen, EDB, VPNEW
12:00-13:00 Lunch & Networking
Novel Molecules and
Innovative Therapeutics
【XDC】
13:00-13:20 Keynote Speech:TBC
Speaker:Connie (Yingqing) Sun, WuXi XDC, Executive Director, US/EU CMC Management
13:20-13:40 Keynote speech: TBC
Speaker:GaniDu, WuXiXDC, Senior Director, Head of Regulatory AffairsNEW
13:40-14:00 Keynote speech: Regulatory considerations for manufacturing and controls of ADC
Speaker:Audrey Jia, ex-FDA OBP CMC reviewer; Founder of Wonderfulland Regulatory Consulting
【BsAb-TCE】
14:00-14:20 Keynote Speech:Unlocking Recent Clinical Progress of mRNA-Based Cancer Vaccines & B-Cell Depletion Therapies
Speaker:Bo Ying, Abogen Biosciences, CEO
14:20-14:40 Keynote Speech:Next Paradigm in TCE Engineering: Nexuce Platform Empowered by SteriMask and Conditional Co-Stimulation
Speaker:Mengqi Fan, Mabwell Bioscience, COO
14:40-15:00 Tea break & Networking
【XDC& BsAb-TCE: Global Development & Regulatory Compliance】
15:00-16:00 Panel Discussion: XDC & TCE Innovation: Balancing Molecular Design, CMC Implementation and
Accelerated Global Development
Panelist:MengqiFan, Nexuce Therapeutics, COO
Audrey Jia, exFDAOBP CMC reviewer; Founder of Wonderfulland Regulatory Consulting
GaniDu, WuXiXDC, Senior Director, Head of Regulatory Affairs
Gang Qin, Gene Quantum, CEO
[Cell Therapy]
16:00-16:40Pnael Disucussion: Global Development and Innovation Opportunities in Cell Therap
Panelist:Xiaoming Peng, Lion TCR, CEO
Ke Zhang, SCG Cell Therapy, CSO
16:40-17:00 Keynote speech: In Vivo Cell Engineering Construct Design
Speaker:Ke Zhang, SCG Cell Therapy, CSO
17:00-17:20 Keynote Speech:Global Registration and Strategic Layout of Innovative iPSC Cell Therapies
Speaker:Xin (Richard) Yuan, Hopstem Biopharmaceutical, Vice President of Quality
17:20-17:40 Keynote speech: Engineering iPSCs for efficient cell therapy manufacturing at industrial scale
Speaker:Yen CHOO, NTU, Lee Kong Chian School of Medicine, Associate Professor of Stem Cell Science and Regenerative Medicine
17:40-18:00 Keynote speech: From Discovery to Therapeutics: Biological Advances Driving the Clinical Translation of MSC-sEVs
Speaker:Sai Kiang Lim, Paracrine Therapeutics, Research Director
Regulation and Market Access
in Southeast Asia
13:00-13:20 Keynote speech:Commercial Success for Biopharmaceuticals Entering ASEAN
Speaker:Shri Sarkar, L.E.K. Consulting, Partner
【Malaysia】
13:20-13:40 Keynote speech:Interpretation of Pharmaceutical Regulatory Policies in Malaysia
Speaker: Zaril Harza Zakaria, NPRA, Head of Investigational Product Evaluation and Safety Section
13:40-14:00 Dialogue: Discussion on Regulatory Compliance Key Points in Malaysia
Panelist:Billy Urudra, MOPI, Executive Director
Zaril Harza Zakaria, NPRA, Head of Investigational Product Evaluation and Safety Sectior
Indonesia
14:00-14:20 Keynote speech: Indonesia’s Evolving Pharmaceutical Landscape: Regulatory Readiness and Market Access for Innovative Therapies
Speaker:Shanti Marlina Sibuea, BPOM, Acting Director of Drugs, Narcotics, Psychotropics, and Precursors Production Control
14:20-14:40 Dialogue: New Landscape of Innovative Biopharma Review in Southeast Asia: From Regulatory Framework to Corporate Implementation
Panelist:Shanti Marlina Sibuea, BPOM, Acting Director of Drugs, Narcotics, Psychotropics, and Precursors Production Control
Miles Shi, Etana, CTO
14:40-15:00 Tea break & Networking
Thermo Fisher Session
Powering Result in Upstream Bioprocessing: From Stable Cell Lines to Scalable Manufacturing
15:00-15:30 Keynote speech:Engineering Selection Pressure and Gene Integration Strategies to Accelerate Stable CHO Cell Line Development
Speaker:Garima Mishra, Thermo Fisher Scientific, Field Applications Scientist Manager, Cell Culture / Cell Therapy, APJ
15:30-16:00 Keynote Speech:The Next Generation of Hydrolysates: Functionally Defined Yeast Extract for CHO-Based Therapeutics and Halal-Certified Peptone for Biologics Development and Manufacturing
Speaker:Chye Boon, Thermo Fisher Scientific, Global Senior Manager, Business Development, Supplements, Bioproduction Group
16:00-16:30 Keynote speech: Smarter Cell Culture Media & Process Development: From High-Throughput Screening and AI in Media Optimization to Raw Material Control and Format Economics
Speaker:Gunjan Bajaj, Thermo Fisher Scientific, Senior Technical Business Development Manager, APJ Bioproduction Group
16:30-17:00 Keynote speech: Accelerating Speed to Commercialization with Single-Use Bioreactors
【9/23】
AI for Pharma
09:00-09:20 Keynote Speech:Leveraging Organoids and AI for Next-Generation Targeted Drug Discovery
Speaker:Haisheng Zhang, Signet Therapeutics, Founder & CEO
09:20-09:40 Keynote speech: Applications of AI in Molecular Design and Target Discovery
Speaker:Lipeng Lai, XtalPi, Co-Founder & CIO
09:40-10:00 Keynote Speech:AI-Driven Novel Drug Development: Linking Target Identification, Molecular Design, and Process Development
10:00-10:20 Keynote Speech:TBC
10:50-11:10 Keynote Speech: Regulatory Compliance for AI in Pharmaceutical R&D
Speaker:Peter Luo, Adagene, Chairman, CEO & President of R&D
11:10-11:30 Keynote speech:AI Tools for New Drug Submissions: Regulatory Opportunities and Practical Constraints
Speaker:Jason LiTrinomab Pharmaceutical, SVP & Global CMC Head
11:30-11:50 Keynote Speech:AI-Powered Design of Next-Generation Complex Biomolecules
12:00-13:00 Lunch & Networking
Advanced Technology
13:00-13:40 Panel Disucussion: Deep Dive into Southeast Asia: How to Break Silos Across Regulation, Manufacturing, Medical Affairs and Commercialization
Panelist:Poh Jeff, Gilead, Regulatory Affairs CMC Lead
Michelle Dee, MSD, Director of Medical Excellence, Global Scientific Content & Medical Information
13:40-14:00Keynote speech:Regulatory CMC Considerations for Biologics Technology Transfer
Speaker:Poh Jeff, Gilead, Regulatory Affairs CMC Lead
14:00-14:20 Keynote Speech:Bispecific Antibody Purification: Toolbox Strategies
Speaker:Wei Zhang, BTI, Principal Scientist & Group Leader, Downstream Processing
14:20-14:40 Keynote Speech:The Role of Digitalization and Automation in Advanced Therapy Medicinal Products Manufacturing
Speaker:Vipul Doshi, Zydus Lifesciences, Chief Quality and Compliance Officer, Global Pharmacovigilance head
14:40-15:00 Keynote speech: From Technology Transfer to Commercial Readiness: De-risking Innovative Biologics Manufacturing in Indonesia
Speaker:Miles Shi, Etana, CTO
15:00-15:20 Keynote Speech:Integrated Drug Product and Device Capability Innovations for HighDose Delivery Solutions
15:20-15:40 Keynote speech:Risk-Based Maintenance Change Control to Meet Global Pharmaceutical Audit Standards
Speaker:Joey Low, Novartis, Senior Maintenance Engineer
15:40-16:00 Keynote speech: Nanotechnology Innovation applications in Pharma industry
Speaker:Deepak Hedge, Cipla (Jiangsu) Pharmaceutical, General Manager & China Site Head
Partnership Opportunities
in Southeast Asia
09:00-09:40 Panel Discussion: Southeast Asia Focus: How Innovative Biotechs Maximize R&D-Manufacturing-BD Collaboration
Moderator: Andy Siow, Luye Pharma (Malaysia), Vice President APAC
Panelist:Gang Qin, Gene Quantum, CEO
Vince Deng, Med-Fine Capital, Partner
Vijay P. Karwal, CBC Group, Managing Director
Lalit Baregama, Symbiotec Pharmalab, CBO
Deepak Hegde, Cipla (Jiangsu) Pharmaceutical, General Manager & China Site Head
09:40-10:20 Panel Discussion:BPD Biologics Process Development Conference Banner
Panelist:Jin Shun, PharmaGend, Managing Director
Jun Feng, J&J, APAC Market Access Director
Daniel Lee, Menarini APAC, Head of Commercial
Jun Hu, WuXi XDC
Andy Siow, Luye Pharma (Malaysia), Vice President APAC
Michelle Dee, MSD, Director of Medical Excellence, Global Scientific Content & Medical Information
10:20-10:50 Tea break & Networking
10:20-10:50 Tea break & Networking
10:50-11:10 Keynote Speech: Beyond Approval: Four Market Access Decisions That Drive Commercial Success in Southeast Asia
Speaker:Jun Feng, J&J, APAC Market Access Director
India
11:10-11:25 Keynote speech: Geopolitics, Supply Chains, and Market Access: Forging a Resilient Biopharma Policy in India
Speaker:Gaurav Arora, BioPharma Centrum, Chief Commercial Officer
11:25-11:40 Dialogue: Regulatory pathways for biologic approval in India
Panelist:Gaurav Arora, BioPharma Centrum, Chief Commercial Officer
Vipul Doshi, Zydus Lifesciences, Chief Quality and Compliance Officer, Global Pharmacovigilance head
【Thailand】
11:40-12:00 Keynote Speech:Commercializing Gene Therapy Beyond the US and Europe: Lessons from Thailand
Speaker:Veerachat Petpisit, Nouvogenes Therapeutics, Founder
12:00-13:00 Tea break & Networking
Small Nucleic Acids/Peptide
/mRNA/Gene Therapy
13:00-13:20 Keynote speech: Superior extra-hepatic delivery PNP Platform and Clinical Application
Speaker: H. Fai Poon, Sirnaomics, CEO
13:20-13:40 Keynote Speech:Synthesis and GMP Manufacturing of Cyclic Peptides and Specially Modified Peptides
Speaker:Liu Dou, Shenzhen Oralead Pharma, CEO
13:40-14:00Keynote speech: TBC
14:00-14:20Keynote speech: Weight Management 2.0 and Beyond: Monthly Efsubaglutide Alfa and a Novel Dual-Target MetabolicPipeline
Speaker:Fan Jiang, Innogen Pharmaceuticals, CFO
14:20-14:40Keynote speech: Implementing Soft Sensors in Fermentation Processes: APractical Approach to Real-Time Monitoring and Process Optimization
Speaker:Junita Dwi Andhini, Bio Farma, QA Engineer
14:40-15:00 Keynote Speech:PEG-free LNPs for targeted delivery of mRNA vaccines
Speaker:Yi Yan, BTI, A*STAR, Distinguished Principal Scientist
15:00-15:20 Keynote Speech:Exploiting cell surface glycans for therapeutics
Speaker:Andre Choo, BTI, A*STAR, Deputy Executive Director
15:20-15:40 Keynote speech: Competitive Landscape and Outlook for Brain-Penetrating Nucleic Acid Delivery Technologies
Speaker:Tinghe Wu, P.S.K Biosciences, CEO
15:40-16:00 Keynote Speech:How sponsors structure and govern CDMO partnerships to ensure delivery and alignment
30分钟！精准锁定合作
2026BPD新加坡1V1约见现已开放注册，8月早鸟优惠限时进行中！无需盲目寒暄，无需无效等待。会前锁定30分钟深度对话，Leading Indonesian pharmaceutical companies, Singapore-based MNCs, and research institutions have already expressed clear demand.The market window never waits—partnerships go to those who act first!立即注册，锁定9月新加坡的关键对话！
BD合作：License-in/out, joint R&D, technology acquisition...
Investment & Financing Matchmaking:与专注于生物医药赛道的投资机构直接对话……
采购合作：供应链采购对接、供应商准入与评估……
长期供应链合作：CDMO/CMO capacity collaboration, regional supply chain layout...
市场准入：Drug registration, commercialization pathways, and distribution network integration across Southeast Asian countries...